3Subtract 2Vector 1Vector
Newsroom Subscribe Contact
LOGO
About us
About us
Company Overview Team Careers
Our Science
Our Science
Pipeline
Pipeline
Investors
Investors
Investor Overview Press Releases Events + Presentations Company Information SEC Filings Stock Information Corporate Governance News Alerts
In the News

Enveric Biosciences Files Provisional Patent for Cannabinoid + Celecoxib Conjugate EV104 after Successful Synthesis [IPO Edge]

February 8, 2022

https://finance.yahoo.com/news/enveric-biosciences-files-provisional-patent-214536823.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZW52ZXJpYy5jb20v&guce_referrer_sig=AQAAAIp7hCuGPXC1J-RCbbPJx9NsQx6Vv_FJkaRKGgsvfN6gOH4gXdA-Asvck2OuCViP4Xuk_XgLTMWBu2e4cKprhWS4Yo9pSGsXuXEBVV9JhnthUovjabluWHepMDqRGj14_EPIjnoXICNk8rB_uf_w13TzI_r9DobeVVdjBEjOFbD6

Company Science Investors News & Media Contact
LOGO
Subtrac3t Vecto2r Vecto1r
Sign up for free updates:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2023 Enveric Biosciences | Terms of Use | Privacy Policy
Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.